About Refarmed Chemicals (India) Private Limited
Data last updated:
Refarmed Chemicals (India) Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Ulfur Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2005PTC169317. Its GSTIN is 07AADCR0404R1Z9 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Rajesh Kumar Maggu and Roland Kraut.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 78 Greater Kailash I, New Delhi, Delhi, India – 110048.
As per the financials filed for FY 2024, the company reported a revenue of ₹38.82 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹3.83 Cr (net margin 9.9%) and EBITDA of ₹5.48 Cr (EBITDA margin 14.1%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 1% over five years.
The company is associated with 1 brand: Refarmed. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website refarmedindia.in.
Company details
CIN history
Refarmed Chemicals (India) has one previous CIN (Corporate Identification Number): U24230AP2005PTC046850. The current CIN is U24230DL2005PTC169317, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230DL2005PTC169317 | Current |
| U24230AP2005PTC046850 | Previous |
Contact details
Refarmed Chemicals (India) Private Limited's registered office is in New Delhi, Delhi. Its website is refarmedindia.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS – 78 Greater Kailash I, New Delhi, Delhi, India – 110048
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Refarmed Chemicals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Refarmed Chemicals (India) operates one associated brand: Refarmed. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of API manufacturing, market strategy, and logistic services | refarmed.ch |
Business activity
The main business activity of Refarmed Chemicals (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Refarmed Chemicals (India) Private Limited, buy the company report.
Financials of Refarmed Chemicals (India) Private Limited
FY 2025 filings availableRefarmed Chemicals (India) Private Limited reported revenue of ₹38.82 Cr (down 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 1% fall in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.48 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.83 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | ||||
| Net Profit Margin | 9.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Refarmed Chemicals (India) Private Limited, buy the company report.
Board of directors of Refarmed Chemicals (India) Private Limited
Refarmed Chemicals (India) has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Maggu | Director | 01 Apr 2015 | 11 Years 7 Months | Current |
| Roland Kraut | Director | 13 May 2025 | 1 Years 5 Months | Current |
| Hansa Zeal Mehta Also directs: DKSH India Private Limited | Director | 29 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Refarmed Chemicals (India) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sapat Global Health Private Limited | ₹39.28 Cr (FY 2024) | 0.0% | Mumbai, Maharashtra, India | |||
| Refarmed Chemicals (India) Private Limitedthis company | ₹38.82 Cr (FY 2024) | ₹3.83 Cr | 9.9% | -1.0% | New Delhi, Delhi, India | |
| A B Roy's Pharmaceuticals Private Limited | ₹38.68 Cr (FY 2025) | 11.0% | Kolkata, West Bengal, India | |||
| Adarsh Medico Private Limited | ₹38.52 Cr (FY 2025) | -9.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Refarmed Chemicals (India) Private Limited, buy the company report.
Auditor
Refarmed Chemicals (India) Private Limited is audited by SUNIL DHAWAN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL DHAWAN & ASSOCIATES | FY 2023 | 006645N |
Shareholding
The shareholding of Refarmed Chemicals (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Refarmed Chemicals (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jul 2014 | 10508582 | Axis Bank Limited | ₹2 Cr | Open | |
| 22 Sep 2010 | 10245593 | Reliance Home Finance Private Limited | ₹1 Cr | Satisfied |
To see the full charge records of Refarmed Chemicals (India) Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Refarmed Chemicals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Refarmed Chemicals (India) Private Limited has 19 MSME Form 1 returns on record between 2016 and 2023, listing 99 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| SRP Logistics Private Limited | |||
| Lee Pharma Limited | |||
| Rakshit Drugs Private Limited | |||
| Lee Pharma Limited | |||
| Apex Healthcare Limited |
To see the full MSME payment records of Refarmed Chemicals (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Refarmed Chemicals (India) has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
Refarmed Chemicals (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCR0404R1Z9 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Refarmed Chemicals (India) Private Limited, buy the company report.
Recent activity
Refarmed Chemicals (India) Private Limited has 13 board changes on record since 2005: 8 appointments and 5 cessations. The latest: Roland Kraut was appointed as Director on 13 May 2025.
7 earlier events are in the company report.
Frequently asked questions
Refarmed Chemicals (India) is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 July 2005 (21+ years old) and is registered under CIN U24230DL2005PTC169317.
Refarmed Chemicals (India) has 3 current directors:
- Rajesh Kumar Maggu - Director
- Roland Kraut - Director
- Hansa Zeal Mehta - Director
The latest financial statements of Refarmed Chemicals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Refarmed Chemicals (India) is 07AADCR0404R1Z9, registered in Delhi.
The CIN (Corporate Identification Number) of Refarmed Chemicals (India) is U24230DL2005PTC169317. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Refarmed Chemicals (India) was incorporated on 13 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Refarmed Chemicals (India) by revenue are Sapat Global Health Private Limited, A B Roy's Pharmaceuticals Private Limited, Adarsh Medico Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Roland Kraut was appointed as Director on 13 May 2025. Vishal Anand Jawale ceased to be Director on 12 Nov 2024. Hansa Zeal Mehta was appointed as Director on 29 Aug 2024. Refarmed Chemicals (India) has 13 board changes on record in total.
Refarmed Chemicals (India) has 19 MSME Form 1 returns on record between 2016 and 2023, listing 99 overdue payments to 6 micro and small suppliers. The latest return was filed on 14 Dec 2023.
Refarmed Chemicals (India) can be reached through the website refarmedindia.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Refarmed Chemicals (India) is at S – 78 Greater Kailash I, New Delhi, Delhi, India – 110048.
Refarmed Chemicals (India) operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
